FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3081520385> ?p ?o ?g. }

• W3081520385 endingPage "6516" @default.
• W3081520385 startingPage "6508" @default.
• W3081520385 abstract "Abstract Background Pneumococcal conjugate vaccine (PCV) effectiveness against radiographic pneumonia in South Asia is unknown. Bangladesh introduced PCV10 in 2015 using a three dose primary series (3 + 0). We sought to measure PCV10 effectiveness for two or more vaccine doses on radiographic pneumonia among vaccine-eligible children in rural Bangladesh. Methods We conducted a matched case-control study over two years from 2015 to 2017 using clinic and community controls in three subdistricts of Sylhet, Bangladesh. Cases were vaccine eligible 3–35 month olds at Upazila Health Complex outpatient clinics with World Health Organization-defined radiographic primary endpoint pneumonia (radiographic pneumonia). Clinic controls were matched to cases within a one week time window by age, sex, and clinic and had an illness unlikely to be Streptococcus pneumoniae; community controls were healthy and similarly matched within a one week time window by age and sex, and distance from the clinic. We estimated adjusted vaccine effectiveness (aVE) using conditional logistic regression. Results We matched 1262 cases with 2707 clinic and 2461 community controls. Overall, aVE using clinic controls was 21.4% (95% confidence interval, −0.2%, 38.4%) for ≥2 PCV10 doses and among 3–11 month olds was 47.3% (10.5%, 69.0%) for three doses. aVE increased with higher numbers of doses in clinic control sets (p = 0.007). In contrast, aVE using community controls was 7.6% (95% confidence interval, −22.2%, 30.0%) for ≥2 doses. We found vaccine introduction in the study area faster and less variable than expected with 75% coverage on average, which reduced power. Information bias may also have affected community controls. Conclusions Clinic control analyses show PCV10 prevented radiographic pneumonia in Bangladesh, especially among younger children receiving three doses. While both analyses were underpowered, community control enrollment – compared to clinic controls – was more difficult in a complex, pluralistic healthcare system. Future studies in comparable settings may consider alternative study designs." @default.
• W3081520385 created "2020-09-08" @default.
• W3081520385 creator A5000146143 @default.
• W3081520385 creator A5011872233 @default.
• W3081520385 creator A5013581513 @default.
• W3081520385 creator A5014703174 @default.
• W3081520385 creator A5015150509 @default.
• W3081520385 creator A5024319683 @default.
• W3081520385 creator A5033061529 @default.
• W3081520385 creator A5033927220 @default.
• W3081520385 creator A5038766581 @default.
• W3081520385 creator A5039144556 @default.
• W3081520385 creator A5040658440 @default.
• W3081520385 creator A5043796567 @default.
• W3081520385 creator A5046036584 @default.
• W3081520385 creator A5051306701 @default.
• W3081520385 creator A5062953269 @default.
• W3081520385 creator A5070156251 @default.
• W3081520385 creator A5070201701 @default.
• W3081520385 creator A5076741396 @default.
• W3081520385 creator A5083262602 @default.
• W3081520385 date "2020-09-01" @default.
• W3081520385 modified "2023-10-16" @default.
• W3081520385 title "Effectiveness of the 10-valent pneumococcal conjugate vaccine against radiographic pneumonia among children in rural Bangladesh: A case-control study" @default.
• W3081520385 cites W1984874957 @default.
• W3081520385 cites W1989563330 @default.
• W3081520385 cites W2056502214 @default.
• W3081520385 cites W2074029700 @default.
• W3081520385 cites W2075357156 @default.
• W3081520385 cites W2088430959 @default.
• W3081520385 cites W2122598469 @default.
• W3081520385 cites W2254951899 @default.
• W3081520385 cites W2549697535 @default.
• W3081520385 cites W2605758023 @default.
• W3081520385 cites W2606199614 @default.
• W3081520385 cites W2619768077 @default.
• W3081520385 cites W2621893872 @default.
• W3081520385 cites W2756982093 @default.
• W3081520385 cites W2800512740 @default.
• W3081520385 cites W2808668519 @default.
• W3081520385 cites W2901989937 @default.
• W3081520385 cites W2936507961 @default.
• W3081520385 doi "https://doi.org/10.1016/j.vaccine.2020.08.035" @default.
• W3081520385 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7520553" @default.
• W3081520385 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32873404" @default.
• W3081520385 hasPublicationYear "2020" @default.
• W3081520385 type Work @default.
• W3081520385 sameAs 3081520385 @default.
• W3081520385 citedByCount "13" @default.
• W3081520385 countsByYear W30815203852021 @default.
• W3081520385 countsByYear W30815203852022 @default.
• W3081520385 countsByYear W30815203852023 @default.
• W3081520385 crossrefType "journal-article" @default.
• W3081520385 hasAuthorship W3081520385A5000146143 @default.
• W3081520385 hasAuthorship W3081520385A5011872233 @default.
• W3081520385 hasAuthorship W3081520385A5013581513 @default.
• W3081520385 hasAuthorship W3081520385A5014703174 @default.
• W3081520385 hasAuthorship W3081520385A5015150509 @default.
• W3081520385 hasAuthorship W3081520385A5024319683 @default.
• W3081520385 hasAuthorship W3081520385A5033061529 @default.
• W3081520385 hasAuthorship W3081520385A5033927220 @default.
• W3081520385 hasAuthorship W3081520385A5038766581 @default.
• W3081520385 hasAuthorship W3081520385A5039144556 @default.
• W3081520385 hasAuthorship W3081520385A5040658440 @default.
• W3081520385 hasAuthorship W3081520385A5043796567 @default.
• W3081520385 hasAuthorship W3081520385A5046036584 @default.
• W3081520385 hasAuthorship W3081520385A5051306701 @default.
• W3081520385 hasAuthorship W3081520385A5062953269 @default.
• W3081520385 hasAuthorship W3081520385A5070156251 @default.
• W3081520385 hasAuthorship W3081520385A5070201701 @default.
• W3081520385 hasAuthorship W3081520385A5076741396 @default.
• W3081520385 hasAuthorship W3081520385A5083262602 @default.
• W3081520385 hasBestOaLocation W30815203851 @default.
• W3081520385 hasConcept C126322002 @default.
• W3081520385 hasConcept C159047783 @default.
• W3081520385 hasConcept C187212893 @default.
• W3081520385 hasConcept C203014093 @default.
• W3081520385 hasConcept C2776152631 @default.
• W3081520385 hasConcept C2777914695 @default.
• W3081520385 hasConcept C2778866548 @default.
• W3081520385 hasConcept C2781253189 @default.
• W3081520385 hasConcept C501593827 @default.
• W3081520385 hasConcept C71924100 @default.
• W3081520385 hasConcept C86803240 @default.
• W3081520385 hasConcept C89423630 @default.
• W3081520385 hasConcept C99454951 @default.
• W3081520385 hasConceptScore W3081520385C126322002 @default.
• W3081520385 hasConceptScore W3081520385C159047783 @default.
• W3081520385 hasConceptScore W3081520385C187212893 @default.
• W3081520385 hasConceptScore W3081520385C203014093 @default.
• W3081520385 hasConceptScore W3081520385C2776152631 @default.
• W3081520385 hasConceptScore W3081520385C2777914695 @default.
• W3081520385 hasConceptScore W3081520385C2778866548 @default.
• W3081520385 hasConceptScore W3081520385C2781253189 @default.
• W3081520385 hasConceptScore W3081520385C501593827 @default.
• W3081520385 hasConceptScore W3081520385C71924100 @default.
• W3081520385 hasConceptScore W3081520385C86803240 @default.
• W3081520385 hasConceptScore W3081520385C89423630 @default.

• next